1
|
Cao L, Zhou Y. Evaluation and Analysis of Cement Raw Meal Homogenization Characteristics Based on Simulated Equipment Models. MATERIALS (BASEL, SWITZERLAND) 2024; 17:2993. [PMID: 38930362 PMCID: PMC11206122 DOI: 10.3390/ma17122993] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/26/2024] [Revised: 06/12/2024] [Accepted: 06/17/2024] [Indexed: 06/28/2024]
Abstract
In recent years, the variability in the composition of cement raw materials has increasingly impacted the quality of cement products. However, there has been relatively little research on the homogenization effects of equipment in the cement production process. Existing studies mainly focus on the primary functions of equipment, such as the grinding efficiency of ball mills, the thermal decomposition in cyclone preheaters, and the thermal decomposition in rotary kilns. This study selected four typical pieces of equipment with significant homogenization functions for an in-depth investigation: ball mills, pneumatic homogenizing silos, cyclone preheaters, and rotary kilns. To assess the homogenization efficacy of each apparatus, scaled-down models of these devices were constructed and subjected to simulated experiments. To improve experimental efficiency and realistically simulate actual production conditions in a laboratory setting, this study used the uniformity of the electrical capacitance of mixed powders instead of compositional uniformity to analyze homogenization effects. The test material in the experiment consisted of a mixture of raw meal from a cement factory with a high dielectric constant and Fe3O4 powder. The parallel plate capacitance method was employed to ascertain the capacitance value of the mixed powder prior to and subsequent to treatment by each equipment model. The fluctuation of the input and output curves was analyzed, and the standard deviation (S), coefficient of variation (R), and homogenization multiplier (H) were calculated in order to evaluate the homogenization effect of each equipment model on the raw meal. The findings of the study indicated that the pneumatic homogenizer exhibited an exemplary homogenization effect, followed by the ball mill. For the ball mill, a higher proportion of small balls in the gradation can significantly enhance the homogenization effect without considering the grinding efficiency. The five-stage cyclone preheater also has a better homogenization effect, while the rotary kiln has a less significant homogenization effect on raw meal. Finally, the raw meal processed by each equipment model was used for clinker calcination and the preparation of cement mortar samples. After curing for three days, the compressive and flexural strengths of the samples were tested, thereby indirectly verifying the homogenization effect of each equipment model on the raw meal. This study helps to understand the homogenization process of raw materials by equipment in cement production and provides certain reference and data support for equipment selection, operation optimization, and quality control in the cement production process.
Collapse
Affiliation(s)
| | - Yongmin Zhou
- College of Materials Science and Engineering, Nanjing Tech University, South Puzhu Road No. 30, Nanjing 211816, China;
| |
Collapse
|
2
|
Supply Chain Design for Blending Technologies. SUSTAINABILITY 2022. [DOI: 10.3390/su14148760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
When optimizing blending technologies, the main objective is to determine the right mixing ratio of the raw materials, depending on the different qualities and costs of the raw materials available. It can be concluded that research is mainly focused on answering technological questions, and only very few studies take into account the logistics processes related to blending technologies, their design, cost-efficiency, utilization and sustainability including energy efficiency and environmental impact. Based on this fact, within the frame of this research the authors describe a new approach, extending the basic model of blending problems by adding new supply chain efficiency-related components that makes it possible to take logistics parameters related to the raw materials supply (available stocks, batch sizes, transport and storage costs, supply chain structure) into consideration. A mathematical model of this supply chain optimization problem for blending technologies is described including routing and assignment problems in the supply chain, while technological objectives are also taken into consideration as technological objective functions and constraints. The optimization problem described in the model is a problem with non-deterministic polynomial-time hardness (NP-hard), which means that there are no known efficient analytical methods to solve the logistics-related supply chain optimization of blending technologies. As a solution algorithm, the authors have used an evolutive solver and a new metrics, which improved the efficiency of the comparison of distances between solutions of routing problems represented by permutation arrays. The scenario analysis, which focuses on the integrated optimization of technological and logistics problems validates the model and evaluates the solution algorithm and the new metrics. Using the mentioned algorithm, the supply chain processes of the blending technologies can be improved from availability, efficiency, sustainability point of view.
Collapse
|
3
|
Mateo-Ortiz D, Villanueva-Lopez V, Muddu SV, Doddridge GD, Alhasson D, Dennis MC. Dry Powder Mixing Is Feasible in Continuous Twin Screw Extruder: Towards Lean Extrusion Process for Oral Solid Dosage Manufacturing. AAPS PharmSciTech 2021; 22:249. [PMID: 34648107 DOI: 10.1208/s12249-021-02148-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2020] [Accepted: 09/22/2021] [Indexed: 11/30/2022] Open
Abstract
Using discrete element method (DEM) modeling and near-infrared (NIR) spectroscopy, the feasibility of powder mixing in the initial pre-melting zones of a twin screw extruder using two independent feeders was studied. Previous work in the pharmaceutical and food industry has focused on mixing when materials are melted or on material homogeneity at the extruder's output. Depending on the formulation, ensuring a fully blended formulation prior to melting may be desired. Experiments were conducted using a Coperion ZSK-18 extruder to evaluate if blend uniformity can be achieved by exploring screw configuration, screw speed, and powder feed rate. As powder exited the extruder and deposited on a conveyor belt, an in-line NIR spectrophotometer measured spectra of material. Chemometric-based models predicted unknown concentrations to evaluate if blend uniformity was achieved. Using the EDEM software, Hertz-Mindlin contact model, and dimensions of the extruder, DEM simulations complemented the experimental work. The DEM computational models provided understanding of mixing patterns inside the extruder at particle scale and helped select the screw configuration before doing experimentation. The simulations showed good axial mixing for all the screw configurations studied, while good cross (radial) mixing was only observed for the screw configuration with 90-degree kneading elements. Therefore, the screw configuration with two 90-degree kneading elements was chosen for the experimental study. The RTD profiles when using a screw configuration with only conveying screw elements are comparable to a plug flow reactor (PFR), while the profiles when using kneading elements are more comparable to an ideal continuous stirred tank reactor (CSTR). For the screw configuration with 90 degrees kneading elements, the mean residence time (MRT) decreases with an increase in the screw speed. Experimental NIR spectra showed that concentrations can be predicted with an error of 2%. It was demonstrated that the twin screw extruder can provide proper dry powder mixing of two powder feed streams based on a unit dose scale, enabling continuous powder mixing prior to the melting zone in the extruder for the formulation studied with a cohesive API. This setup may also work for other types of formulations. These studies can help in developing lean hot melt as well as wet extrusion/granulation processes using twin screw extruders for the continuous manufacturing of oral solid dosage products.
Collapse
|
4
|
Jiwa N, Ozalp Y, Yegen G, Aksu B. Critical Tools in Tableting Research: Using Compaction Simulator and Quality by Design (QbD) to Evaluate Lubricants' Effect in Direct Compressible Formulation. AAPS PharmSciTech 2021; 22:151. [PMID: 33977355 DOI: 10.1208/s12249-021-02004-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Accepted: 03/27/2021] [Indexed: 11/30/2022] Open
Abstract
As commonly known, the product development stage is quite complex, requires intensive knowledge, and is time-consuming. The selection of the excipients with the proper functionality and their corresponding levels is critical to drug product performance. The objective of this study was to apply quality by design (QbD) principles for formulation development and to define the desired product quality profile (QTPP) and critical quality attributes (CQA) of a product. QbD is a risk- and science-based holistic approach for upgraded pharmaceutical development. In this study, Ibuprofen DC 85W was used as a model drug, Cellactose® 80 along with MicroceLac® 100 as a filler, and magnesium stearate, stearic acid, and sodium stearyl fumarate as lubricants. By applying different formulation parameters to the filler and lubricants, the QbD approach furthers the understanding of the effect of critical formulation and process parameters on CQAs and the contribution to the overall quality of the drug product. An experimental design study was conducted to determine the changes of the obtained outputs of the formulations, which were evaluated using the Modde Pro 12.1 statistical computer program that enables optimization by modeling complex relationships. The results of the optimum formulation revealed that MicroceLac® 100 was the superior filler, while magnesium stearate at 1% was the optimum lubricant. A design space that indicates the safety operation limits for the process and formulation variables was also created. This study enriches the understanding of the effect of excipients in formulation and assists in enhancing formulation design using experimental design and mathematical modeling methods in the frame of the QbD approach.
Collapse
|
5
|
Review of sensing technologies for measuring powder density variations during pharmaceutical solid dosage form manufacturing. Trends Analyt Chem 2021. [DOI: 10.1016/j.trac.2020.116147] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
6
|
Pedersen T, Rantanen J, Naelapää K, Skibsted E. Near infrared analysis of pharmaceutical powders with empirical target distribution optimization (ETDO). J Pharm Biomed Anal 2020; 181:113059. [PMID: 31978645 DOI: 10.1016/j.jpba.2019.113059] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2019] [Revised: 12/13/2019] [Accepted: 12/18/2019] [Indexed: 11/28/2022]
Abstract
Near infrared (NIR) spectroscopy is a well-established method for analysis of pharmaceutical products, and especially useful for process monitoring and control of continuous production due to high sample throughput. In this work, a previously established method called empirical target distribution optimization (ETDO) wherein reference sample values using information from model prediction of the calibration data was used as a tool to improve the performance of NIR partial least squares (PLS) models. Model performance was assessed using root mean square error (R2), bias and accuracy in prediction of test samples. A target value selection threshold was tested to assess the ETDO procedure for NIR analysis of powder samples. The amount of specific variation captured by the model was examined and compared for models calibrated with and without ETDO. The results reported in this work suggests that PLS models optimized with ETDO of reference values can provide more specific PLS models for NIR analysis for complex powder mixtures. In addition, the model optimization method could also be applied as a tool to verify the necessary amount of PLS components to produce robust models. The ETDO method presented in this work is an approach that could be applied in the development of continuous blending or tableting processes where robust in-line quantitative analysis of powder samples is needed.
Collapse
Affiliation(s)
- Troels Pedersen
- Novo Nordisk A/S, Oral Analytical Development, Novo Nordisk Park, Måløv, Denmark
| | - Jukka Rantanen
- Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
| | - Kaisa Naelapää
- Novo Nordisk A/S, Oral Formulation Research, Novo Nordisk Park, Måløv, Denmark
| | - Erik Skibsted
- Novo Nordisk A/S, Oral Analytical Development, Novo Nordisk Park, Måløv, Denmark.
| |
Collapse
|
7
|
Grangeia HB, Silva C, Simões SP, Reis MS. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives. Eur J Pharm Biopharm 2020; 147:19-37. [DOI: 10.1016/j.ejpb.2019.12.007] [Citation(s) in RCA: 55] [Impact Index Per Article: 13.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2019] [Revised: 12/03/2019] [Accepted: 12/11/2019] [Indexed: 12/17/2022]
|
8
|
Singh BN. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications. AAPS PharmSciTech 2019; 20:313. [PMID: 31529232 DOI: 10.1208/s12249-019-1515-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2019] [Accepted: 08/18/2019] [Indexed: 11/30/2022] Open
Abstract
An integrated approach based on QbD and PAT provides a systematic and innovative framework for product development, manufacturing, and quality risk management. In this context, the significance of the outcome of design of experiments (DOEs) to the selection of the product design, robust commercial manufacturing process, design space, and overall control strategy remains vital for the success of a drug product throughout its life cycle. This paper aims at discussing selected recent DOE case studies conducted during QbD-based and integrated QbD/PAT-based development of solid oral formulations and process improvement studies. The main focus of this paper is to highlight the rationales and importance of design selection during development and applications of mathematical models and statistical tools in analyzing DOE and PAT data for developing a design space, control strategy, and improved process monitoring. A total of 25 case studies (includes 9 PAT application studies) have been discussed in this paper which cover 11 manufacturing processes commonly utilized for solid dosage forms. Two case studies relevant to selection of packaging design for solid dosage forms are also briefly discussed to complete the scope. Overall, for a successful modern QbD approach, it is highly important that DOEs are conducted and analyzed in a logical sequence which involves designs that are phase-appropriate and quality-driven and facilitate both statistical and chemometric thinking at each development stage. This approach can result into higher regulatory flexibility along with lower economic burden during life cycle of a product, irrespective of regulatory path used (NDA or ANDA).
Collapse
|
9
|
Castillo Henríquez L, Vargas Zúñiga R, Carazo Berrocal G, Madrigal Redondo G, Calvo Guzmán B, Baltodano Viales E. Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach. Drug Dev Ind Pharm 2019; 45:1674-1681. [PMID: 31378098 DOI: 10.1080/03639045.2019.1652637] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Objective: The main objective of this research is to develop an immediate release Rupatadine fumarate 10 mg tablets formulation by direct compression, through a Quality by Design approach in Costa Rica. Methods: According to a Quality by Design approach; Target Product Profile, Quality Target Product Profile, and the Critical Quality Attributes were defined. In the preformulation study, compatibility tests were carried out between the raw materials. The Critical Material Attributes were established using Quality Risk Management. Three formulation prototypes were prepared by direct compression and its Critical Process Parameters were defined. The analysis of the prototypes was realized in terms of organoleptic properties, identification, potency, content uniformity, dissolution, disintegration, friability and loss by drying. Results: All the prototypes showed a white or slightly pink surface, potency between 90.0 -110.0 % of the labeling, an acceptance value for the content uniformity lower than the specification (AV < 15), the dissolved amount of active pharmaceutical ingredient was greater than 85.0 % at 30 minutes, friability less than 1.0 %, a disintegration time less than 15 minutes and moisture content less than 2.0 %. Conclusions: The approaching of a Quality by Design model to the current development allowed to obtain satisfactory results in the three formulation prototypes. The excipients to be used can be lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, pregelatinized starch, magnesium stearate, stearic acid, and PVP K-30.
Collapse
Affiliation(s)
- Luis Castillo Henríquez
- Faculty of Pharmacy, Pharmaceutical Physical Chemistry Laboratory, University of Costa Rica , San José , Costa Rica.,Phytopharmacology and Pharmaceutical Technology Laboratory (LAFITEC), Institute of Pharmaceutical Research (INIFAR ), San José , Costa Rica
| | - Rolando Vargas Zúñiga
- Biopharmacy and Pharmacokinetics Laboratory (LABIOFAR), Institute of Pharmaceutical Research (INIFAR) , San José , Costa Rica
| | - Gustavo Carazo Berrocal
- Faculty of Pharmacy, Pharmaceutical Physical Chemistry Laboratory, University of Costa Rica , San José , Costa Rica.,Phytopharmacology and Pharmaceutical Technology Laboratory (LAFITEC), Institute of Pharmaceutical Research (INIFAR ), San José , Costa Rica
| | - German Madrigal Redondo
- Faculty of Pharmacy, Pharmaceutical Physical Chemistry Laboratory, University of Costa Rica , San José , Costa Rica.,Biopharmacy and Pharmacokinetics Laboratory (LABIOFAR), Institute of Pharmaceutical Research (INIFAR) , San José , Costa Rica
| | | | - Eleaneth Baltodano Viales
- Biopharmacy and Pharmacokinetics Laboratory (LABIOFAR), Institute of Pharmaceutical Research (INIFAR) , San José , Costa Rica.,Quality Control of Medications Laboratory, University of Costa Rica Pharmacy Faculty , San José , Costa Rica
| |
Collapse
|
10
|
Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Int J Pharm 2019; 567:118445. [DOI: 10.1016/j.ijpharm.2019.06.036] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2019] [Revised: 06/14/2019] [Accepted: 06/15/2019] [Indexed: 11/22/2022]
|
11
|
Hilden J, Sullivan M, Polizzi M, Wade J, Greer J, Keeney M. Power consumption during oscillatory mixing of pharmaceutical powders. POWDER TECHNOL 2018. [DOI: 10.1016/j.powtec.2018.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
12
|
Feasibility of near infrared and Raman hyperspectral imaging combined with multivariate analysis to assess binary mixtures of food powders. POWDER TECHNOL 2018. [DOI: 10.1016/j.powtec.2018.06.025] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
13
|
Ko SJ, Lee JH, Kang CY, Park JB. Granulation development in batch-to-batch and continuous processes from a quality by design perspective. J Drug Deliv Sci Technol 2018. [DOI: 10.1016/j.jddst.2018.04.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
|
15
|
Elia A, Cocchi M, Cottini C, Riolo D, Cafiero C, Bosi R, Lutero E. Multivariate data analysis to assess dry powder inhalers performance from powder properties. POWDER TECHNOL 2016. [DOI: 10.1016/j.powtec.2016.07.002] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
16
|
Fonteyne M, Vercruysse J, De Leersnyder F, Besseling R, Gerich A, Oostra W, Remon JP, Vervaet C, De Beer T. Blend uniformity evaluation during continuous mixing in a twin screw granulator by in-line NIR using a moving F-test. Anal Chim Acta 2016; 935:213-23. [PMID: 27543030 DOI: 10.1016/j.aca.2016.07.020] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2016] [Accepted: 07/18/2016] [Indexed: 11/25/2022]
Abstract
This study focuses on the twin screw granulator of a continuous from-powder-to-tablet production line. Whereas powder dosing into the granulation unit is possible from a container of preblended material, a truly continuous process uses several feeders (each one dosing an individual ingredient) and relies on a continuous blending step prior to granulation. The aim of the current study was to investigate the in-line blending capacity of this twin screw granulator, equipped with conveying elements only. The feasibility of in-line NIR (SentroPAT, Sentronic GmbH, Dresden, Germany) spectroscopy for evaluating the blend uniformity of powders after the granulator was tested. Anhydrous theophylline was used as a tracer molecule and was blended with lactose monohydrate. Theophylline and lactose were both fed from a different feeder into the twin screw granulator barrel. Both homogeneous mixtures and mixing experiments with induced errors were investigated. The in-line spectroscopic analyses showed that the twin screw granulator is a useful tool for in-line blending in different conditions. The blend homogeneity was evaluated by means of a novel statistical method being the moving F-test method in which the variance between two blocks of collected NIR spectra is evaluated. The α- and β-error of the moving F-test are controlled by using the appropriate block size of spectra. The moving F-test method showed to be an appropriate calibration and maintenance free method for blend homogeneity evaluation during continuous mixing.
Collapse
Affiliation(s)
- Margot Fonteyne
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium.
| | - Jurgen Vercruysse
- Laboratory of Pharmaceutical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium
| | - Fien De Leersnyder
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium
| | | | | | | | - Jean Paul Remon
- Laboratory of Pharmaceutical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium
| | - Chris Vervaet
- Laboratory of Pharmaceutical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Ghent University, Ottergemsesteenweg 460, Ghent, Belgium.
| |
Collapse
|
17
|
Dai X, Song H, Liu W, Yao S, Wang G. On-line UV-NIR spectroscopy as a process analytical technology (PAT) tool for on-line and real-time monitoring of the extraction process of Coptis Rhizome. RSC Adv 2016. [DOI: 10.1039/c5ra23688f] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
UV-NIR spectroscopy connected method as a tool for on-line and real-time monitoring of Coptis Rhizome extraction process.
Collapse
Affiliation(s)
- Xuezhi Dai
- School of Chemical Engineering
- Sichuan University
- Chengdu 610065
- China
| | - Hang Song
- School of Chemical Engineering
- Sichuan University
- Chengdu 610065
- China
| | - Wen Liu
- School of Chemical Engineering
- Sichuan University
- Chengdu 610065
- China
| | - Shun Yao
- School of Chemical Engineering
- Sichuan University
- Chengdu 610065
- China
| | - Gang Wang
- School of Chemical Engineering
- Sichuan University
- Chengdu 610065
- China
- Department of Pharmacy
| |
Collapse
|
18
|
Wu H, Read E, White M, Chavez B, Brorson K, Agarabi C, Khan M. Real time monitoring of bioreactor mAb IgG3 cell culture process dynamics via Fourier transform infrared spectroscopy: Implications for enabling cell culture process analytical technology. Front Chem Sci Eng 2015. [DOI: 10.1007/s11705-015-1533-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Miyano T, Nakagawa H, Watanabe T, Minami H, Sugiyama H. Operationalizing Maintenance of Calibration Models Based on Near-Infrared Spectroscopy by Knowledge Integration. J Pharm Innov 2015. [DOI: 10.1007/s12247-015-9226-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Liu X, Ma Q, Liu S, Shi X, Zhang Q, Wu Z, Qiao Y. Monitoring As and Hg variation in An-Gong-Niu-Huang Wan (AGNH) intermediates in a pilot scale blending process using laser-induced breakdown spectroscopy. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2015; 151:547-552. [PMID: 26162343 DOI: 10.1016/j.saa.2015.07.002] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Revised: 06/30/2015] [Accepted: 07/01/2015] [Indexed: 06/04/2023]
Abstract
Laser-induced breakdown spectroscopy (LIBS) was used to assess the cinnabar and realgar blending of An-Gong-Niu-Huang Wan (AGNH) in a pilot-scale experiment, including the blending end-point. The blending variability of two mineral medicines, cinnabar and realgar, were measured by signal relative intensity changing rate (RICR) and moving window standard deviation (MWSD) based on LIBS. Meanwhile, relative concentration changing rate (RCCR) was obtained based on the reference method involving inductively coupled plasma optical emission spectrometry (ICP-OES). The LIBS result was consistent with ICP-OES at blending end-point determinations of both mineral medicines. Unlike the ICP-OES method, LIBS does not have an elaborate digestion procedure. LIBS is a promising and rapid technique to understand the blending process of Chinese Materia Medica (CMM) containing cinnabar and realgar. These results demonstrate the potential of LIBS in monitoring CMM pharmaceutical production.
Collapse
Affiliation(s)
- Xiaona Liu
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China
| | - Qun Ma
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China
| | - Shanshan Liu
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China
| | - Xinyuan Shi
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China
| | - Qiao Zhang
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China
| | - Zhisheng Wu
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China.
| | - Yanjiang Qiao
- Beijing University of Chinese Medicine, 100102, China; Pharmaceutical Engineering and New Drug Development of TCM of Ministry of Education, 100102, China; Key Laboratory of TCM-information Engineering of State Administration of TCM, Beijing 100102, China; Beijing Key Laboratory for Basic and Development Research on Chinese Medicine, Beijing 100102, China.
| |
Collapse
|
21
|
Scheibelhofer O, Grabner B, Bondi RW, Igne B, Sacher S, Khinast JG. Designed Blending for Near Infrared Calibration. J Pharm Sci 2015; 104:2312-22. [PMID: 25980978 DOI: 10.1002/jps.24488] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2015] [Revised: 03/20/2015] [Accepted: 04/17/2015] [Indexed: 11/11/2022]
Affiliation(s)
- Otto Scheibelhofer
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
- Institute of Process and Particle Engineering, University of Technology, Graz, Austria
| | - Bianca Grabner
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | | | - Benoît Igne
- GlaxoSmithKline, King of Prussia, Pennsylvania
| | - Stephan Sacher
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | - Johannes G Khinast
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
- Institute of Process and Particle Engineering, University of Technology, Graz, Austria
| |
Collapse
|
22
|
Simon LL, Pataki H, Marosi G, Meemken F, Hungerbühler K, Baiker A, Tummala S, Glennon B, Kuentz M, Steele G, Kramer HJM, Rydzak JW, Chen Z, Morris J, Kjell F, Singh R, Gani R, Gernaey KV, Louhi-Kultanen M, O’Reilly J, Sandler N, Antikainen O, Yliruusi J, Frohberg P, Ulrich J, Braatz RD, Leyssens T, von Stosch M, Oliveira R, Tan RBH, Wu H, Khan M, O’Grady D, Pandey A, Westra R, Delle-Case E, Pape D, Angelosante D, Maret Y, Steiger O, Lenner M, Abbou-Oucherif K, Nagy ZK, Litster JD, Kamaraju VK, Chiu MS. Assessment of Recent Process Analytical Technology (PAT) Trends: A Multiauthor Review. Org Process Res Dev 2015. [DOI: 10.1021/op500261y] [Citation(s) in RCA: 269] [Impact Index Per Article: 29.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
| | - Hajnalka Pataki
- Department
of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary
| | - György Marosi
- Department
of Organic Chemistry and Technology, Budapest University of Technology and Economics, Műegyetem rkp. 3, H-1111 Budapest, Hungary
| | - Fabian Meemken
- Department
of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg
1, 8093 Zürich, Switzerland
| | - Konrad Hungerbühler
- Department
of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg
1, 8093 Zürich, Switzerland
| | - Alfons Baiker
- Department
of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg
1, 8093 Zürich, Switzerland
| | - Srinivas Tummala
- Chemical
Development, Bristol-Myers Squibb Company, One Squibb Dr, New Brunswick, New Jersey 08903, United States
| | - Brian Glennon
- Synthesis
and Solid State Pharmaceutical Centre, School of Chemical and Bioprocess
Engineering, University College Dublin, Belfield, Dublin 4, Ireland
- APC Ltd, Belfield Innovation
Park, Dublin 4, Ireland
| | - Martin Kuentz
- School of Life
Sciences, Institute of Pharma Technology, University of Applied Sciences and Arts Northwestern Switzerland, Gründenstrasse 40, 4132 Muttenz, Switzerland
| | - Gerry Steele
- PharmaCryst Consulting
Ltd., Loughborough, Leicestershire LE11 3HN, U.K
| | - Herman J. M. Kramer
- Intensified Reaction & Separation Systems, Delft University of Technology, Leeghwaterstraat 39, 2628 CB Delft, The Netherlands
| | - James W. Rydzak
- GlaxoSmithKline Pharmaceuticals, 709 Swedeland Rd, King of
Prussia, Pennsylvania 19406, United States
| | - Zengping Chen
- State Key
Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry
and Chemical Engineering, Hunan University, Changsha, Hunan 410082, PR China
| | - Julian Morris
- Centre for Process Analytics & Control Technology, School of Chemical Engineering & Advanced Materials, Newcastle University, Newcastle upon Tyne, Tyne and Wear NE17RU, U.K
| | - Francois Kjell
- Siemens nv/sa,
Industry
Automation − SIPAT Industry Software, Marie Curie Square 30, 1070 Brussels, Belgium
| | - Ravendra Singh
- CAPEC-PROCESS,
Department of Chemical and Biochemical Engineering, Technical University of Denmark (DTU), Building 229, DK-2800 Lyngby, Denmark
| | - Rafiqul Gani
- CAPEC-PROCESS,
Department of Chemical and Biochemical Engineering, Technical University of Denmark (DTU), Building 229, DK-2800 Lyngby, Denmark
| | - Krist V. Gernaey
- CAPEC-PROCESS,
Department of Chemical and Biochemical Engineering, Technical University of Denmark (DTU), Building 229, DK-2800 Lyngby, Denmark
| | - Marjatta Louhi-Kultanen
- Department
of Chemical Technology, Lappeenranta University of Technology, P.O. Box 20, FI-53851 Lappeenranta, Finland
| | - John O’Reilly
- Roche Ireland
Limited, Clarecastle, Co. Clare, Ireland
| | - Niklas Sandler
- Pharmaceutical
Sciences Laboratory, Department of Biosciences, Abo Akademi University, Artillerigatan 6, 20520 Turku, Finland
| | - Osmo Antikainen
- Division
of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland
| | - Jouko Yliruusi
- Division
of Pharmaceutical Technology, Faculty of Pharmacy, University of Helsinki, Yliopistonkatu 4, 00100 Helsinki, Finland
| | - Patrick Frohberg
- Center of
Engineering Science, Thermal Process Engineering, Martin Luther University Halle-Wittenberg, D-06099 Halle (Saale), Germany
| | - Joachim Ulrich
- Center of
Engineering Science, Thermal Process Engineering, Martin Luther University Halle-Wittenberg, D-06099 Halle (Saale), Germany
| | - Richard D. Braatz
- Massachusetts Institute
of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
| | - Tom Leyssens
- Institute
of Condensed Matter and Nanosciences, Université Catholique de Louvain, Place Louis Pasteur 1, 1348 Louvain-la-Neuve, Belgium
| | - Moritz von Stosch
- REQUIMTE
- Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 1099-085 Caparica, Portugal
- HybPAT, Caparica, Portugal
| | - Rui Oliveira
- REQUIMTE
- Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 1099-085 Caparica, Portugal
- HybPAT, Caparica, Portugal
| | - Reginald B. H. Tan
- Institute
of Chemical and Engineering Sciences, A*Star, 1 Pesek Road, Singapore 627833
- Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576
| | - Huiquan Wu
- Division
of Product Quality Research, Office of Testing and Research, Office
of Pharmaceutical Science, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland 20993, United States
| | - Mansoor Khan
- Division
of Product Quality Research, Office of Testing and Research, Office
of Pharmaceutical Science, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland 20993, United States
| | - Des O’Grady
- Mettler Toledo
AutoChem, 7075 Samuel Morse Drive, Columbia, Maryland 20146, United States
| | - Anjan Pandey
- Mettler Toledo
AutoChem, 7075 Samuel Morse Drive, Columbia, Maryland 20146, United States
| | - Remko Westra
- FMC Technologies B.V., Delta 101, 6825 MN Arnhem, The Netherlands
| | - Emmanuel Delle-Case
- University of Tulsa, 800 South Tucker
Drive, Tulsa, Oklahoma 74104, United States
| | - Detlef Pape
- ABB Corporate Research Center, Segelhofstrasse
1K, 5405, Dättwil, Baden, Switzerland
| | - Daniele Angelosante
- ABB Corporate Research Center, Segelhofstrasse
1K, 5405, Dättwil, Baden, Switzerland
| | - Yannick Maret
- ABB Corporate Research Center, Segelhofstrasse
1K, 5405, Dättwil, Baden, Switzerland
| | - Olivier Steiger
- ABB Corporate Research Center, Segelhofstrasse
1K, 5405, Dättwil, Baden, Switzerland
| | - Miklós Lenner
- ABB Corporate Research Center, Segelhofstrasse
1K, 5405, Dättwil, Baden, Switzerland
| | - Kaoutar Abbou-Oucherif
- School of
Chemical Engineering, Purdue University, West Lafayette, Indiana 47906, United States
| | - Zoltan K. Nagy
- School of
Chemical Engineering, Purdue University, West Lafayette, Indiana 47906, United States
- Chemical
Engineering Department, Loughborough University, Loughborough, LE11 3TU, U.K
| | - James D. Litster
- School of
Chemical Engineering, Purdue University, West Lafayette, Indiana 47906, United States
| | - Vamsi Krishna Kamaraju
- Synthesis
and Solid State Pharmaceutical Centre, School of Chemical and Bioprocess
Engineering, University College Dublin, Belfield, Dublin 4, Ireland
- Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576
| | - Min-Sen Chiu
- Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore 117576
| |
Collapse
|
23
|
Spectral fluctuation dividing for efficient wavenumber selection: Application to estimation of water and drug content in granules using near infrared spectroscopy. Int J Pharm 2014; 475:504-13. [DOI: 10.1016/j.ijpharm.2014.09.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2014] [Revised: 08/22/2014] [Accepted: 09/06/2014] [Indexed: 11/19/2022]
|
24
|
Modeling strategies for pharmaceutical blend monitoring and end-point determination by near-infrared spectroscopy. Int J Pharm 2014; 473:219-31. [DOI: 10.1016/j.ijpharm.2014.06.061] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2014] [Revised: 06/06/2014] [Accepted: 06/25/2014] [Indexed: 11/21/2022]
|
25
|
Wu H, White M, Khan M. An Integrated Process Analytical Technology (PAT) Approach for Process Dynamics-Related Measurement Error Evaluation and Process Design Space Development of a Pharmaceutical Powder Blending Bed. Org Process Res Dev 2014. [DOI: 10.1021/op500085m] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Huiquan Wu
- Division
of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), Food and Drug Administration (FDA), FDA White Oak Campus Building 64,
10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Maury White
- Division
of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), Food and Drug Administration (FDA), FDA White Oak Campus Building 64,
10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Mansoor Khan
- Division
of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), Food and Drug Administration (FDA), FDA White Oak Campus Building 64,
10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| |
Collapse
|
26
|
An Integrated Process Analytical Technology (PAT) Approach for Pharmaceutical Crystallization Process Understanding to Ensure Product Quality and Safety: FDA Scientist’s Perspective. Org Process Res Dev 2014. [DOI: 10.1021/op500056a] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
27
|
Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, Woodcock J. Understanding pharmaceutical quality by design. AAPS JOURNAL 2014; 16:771-83. [PMID: 24854893 DOI: 10.1208/s12248-014-9598-3] [Citation(s) in RCA: 617] [Impact Index Per Article: 61.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2013] [Accepted: 03/24/2014] [Indexed: 11/30/2022]
Abstract
This review further clarifies the concept of pharmaceutical quality by design (QbD) and describes its objectives. QbD elements include the following: (1) a quality target product profile (QTPP) that identifies the critical quality attributes (CQAs) of the drug product; (2) product design and understanding including identification of critical material attributes (CMAs); (3) process design and understanding including identification of critical process parameters (CPPs), linking CMAs and CPPs to CQAs; (4) a control strategy that includes specifications for the drug substance(s), excipient(s), and drug product as well as controls for each step of the manufacturing process; and (5) process capability and continual improvement. QbD tools and studies include prior knowledge, risk assessment, mechanistic models, design of experiments (DoE) and data analysis, and process analytical technology (PAT). As the pharmaceutical industry moves toward the implementation of pharmaceutical QbD, a common terminology, understanding of concepts and expectations are necessary. This understanding will facilitate better communication between those involved in risk-based drug development and drug application review.
Collapse
Affiliation(s)
- Lawrence X Yu
- Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, 20993, USA,
| | | | | | | | | | | | | |
Collapse
|
28
|
Nakagawa H, Kano M, Hasebe S, Miyano T, Watanabe T, Wakiyama N. Verification of model development technique for NIR-based real-time monitoring of ingredient concentration during blending. Int J Pharm 2014; 471:264-75. [PMID: 24834879 DOI: 10.1016/j.ijpharm.2014.05.013] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2013] [Revised: 04/09/2014] [Accepted: 05/09/2014] [Indexed: 11/29/2022]
Abstract
There has been a considerable research on the process analytical technology (PAT) and real-time monitoring based on NIR, but the model development is still an important issue and persons in charge have difficulty in building good models. In this study, to realize efficient NIR-based real-time monitoring of ingredient concentration and establish a model development method, we investigated the effect of a calibration set, spectral preprocessing, wavelengths, and other factors on the prediction error through pilot and commercial scale blending experiments. The results confirmed that the small prediction error was realized by a calibration set, including dynamic measurement spectra acquired with the target blender. In addition, the results demonstrated that locally weighted partial least squares (LW-PLS) achieved the smaller prediction error than conventional PLS. The present study has also clarified that spectral preprocessing methods and wavelengths selected to build a model affect the prediction error of ingredient concentration interactively. A wide wavelength range should be selected when the spectral preprocessing does not lessen the effect of baseline variation, while a narrow wavelength range should be selected when it strongly decreases the effect.
Collapse
Affiliation(s)
- Hiroshi Nakagawa
- Formulation Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., Kanagawa, Japan.
| | - Manabu Kano
- Department of Systems Science, Kyoto University, Kyoto, Japan
| | - Shinji Hasebe
- Department of Chemical Engineering, Kyoto University, Kyoto, Japan
| | - Takuya Miyano
- Formulation Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., Kanagawa, Japan
| | - Tomoyuki Watanabe
- Formulation Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., Kanagawa, Japan
| | - Naoki Wakiyama
- Formulation Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., Kanagawa, Japan
| |
Collapse
|
29
|
Kushner J, Langdon BA, Hicks I, Song D, Li F, Kathiria L, Kane A, Ranade G, Agarwal K. A Quality-by-Design Study for an Immediate-Release Tablet Platform: Examining the Relative Impact of Active Pharmaceutical Ingredient Properties, Processing Methods, and Excipient Variability on Drug Product Quality Attributes. J Pharm Sci 2014; 103:527-38. [DOI: 10.1002/jps.23810] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2013] [Revised: 10/22/2013] [Accepted: 10/29/2013] [Indexed: 11/10/2022]
|
30
|
Wu H, White M, Berendt R, Foringer RD, Khan M. Integrated Process Analytical Technology Approach for Nucleation Induction Time Measurement and Nucleation Mechanism Assessment for a Dynamic Multicomponent Pharmaceutical Antisolvent Crystallization System. Ind Eng Chem Res 2014. [DOI: 10.1021/ie4036466] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Huiquan Wu
- Division of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), US Food and Drug Administration (FDA), Life Science Building
64, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Maury White
- Division of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), US Food and Drug Administration (FDA), Life Science Building
64, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Robert Berendt
- Division of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), US Food and Drug Administration (FDA), Life Science Building
64, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Ryan D. Foringer
- Division of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), US Food and Drug Administration (FDA), Life Science Building
64, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| | - Mansoor Khan
- Division of Product Quality
Research (DPQR, HFD-940), Office of Testing and Research (OTR), Office
of Pharmaceutical Sciences (OPS), Center for Drug Evaluation and Research
(CDER), US Food and Drug Administration (FDA), Life Science Building
64, FDA White Oak Campus, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993, United States
| |
Collapse
|
31
|
Yerlikaya F, Ozgen A, Vural I, Guven O, Karaagaoglu E, Khan MA, Capan Y. Development and Evaluation of Paclitaxel Nanoparticles Using a Quality-by-Design Approach. J Pharm Sci 2013; 102:3748-61. [DOI: 10.1002/jps.23686] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2013] [Revised: 06/26/2013] [Accepted: 07/10/2013] [Indexed: 11/08/2022]
|
32
|
Real-time monitoring of lubrication properties of magnesium stearate using NIR spectrometer and thermal effusivity sensor. Int J Pharm 2013; 441:402-13. [DOI: 10.1016/j.ijpharm.2012.11.014] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2012] [Revised: 10/10/2012] [Accepted: 11/09/2012] [Indexed: 10/27/2022]
|
33
|
Real-time determination of critical quality attributes using near-infrared spectroscopy: A contribution for Process Analytical Technology (PAT). Talanta 2012; 97:163-70. [DOI: 10.1016/j.talanta.2012.04.012] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2012] [Revised: 03/29/2012] [Accepted: 04/04/2012] [Indexed: 11/19/2022]
|
34
|
Wu H, Khan M. THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical Process Analytical Technology (PAT) applications. J Mol Struct 2012. [DOI: 10.1016/j.molstruc.2012.04.019] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
35
|
Momose W, Yoshino H, Katakawa Y, Yamashita K, Imai K, Sako K, Kato E, Irisawa A, Yonemochi E, Terada K. Applying terahertz technology for nondestructive detection of crack initiation in a film-coated layer on a swelling tablet. RESULTS IN PHARMA SCIENCES 2012; 2:29-37. [PMID: 25755992 DOI: 10.1016/j.rinphs.2012.04.001] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/24/2012] [Revised: 04/03/2012] [Accepted: 04/05/2012] [Indexed: 10/28/2022]
Abstract
Here, we describe a nondestructive approach using terahertz wave to detect crack initiation in a film-coated layer on a drug tablet. During scale-up and scale-down of the film coating process, differences in film density and gaps between the film-coated layer and the uncoated tablet were generated due to differences in film coating process parameters, such as the tablet-filling rate in the coating machine, spray pressure, and gas-liquid ratio etc. Tablets using the PEO/PEG formulation were employed as uncoated tablets. We found that heat and humidity caused tablets to swell, thereby breaking the film-coated layer. Using our novel approach with terahertz wave nondestructively detect film surface density (FSD) and interface density differences (IDDs) between the film-coated layer and an uncoated tablet. We also found that a reduced FSD and IDD between the film-coated layer and uncoated tablet increased the risk of crack initiation in the film-coated layer, thereby enabling us to nondestructively predict initiation of cracks in the film-coated layer. Using this method, crack initiation can be nondestructively assessed in swelling tablets after the film coating process without conducting accelerated stability tests, and film coating process parameters during scale-up and scale-down studies can be appropriately established.
Collapse
Affiliation(s)
- Wataru Momose
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan ; Faculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan ; PAT Committee, Japan Society of Pharmaceutical Machinery and Engineering, Miyoshi Bld. 3F, 2-7-3 Kandata-cho, Chiyoda-ku, Tokyo 101-0046, Japan
| | - Hiroyuki Yoshino
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan
| | - Yoshifumi Katakawa
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan
| | - Kazunari Yamashita
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan
| | - Keiji Imai
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan
| | - Kazuhiro Sako
- Pharmaceutical Research & Technology Laboratories, Astellas Pharma Inc., Yaizu, Shizuoka 425-0072, Japan
| | - Eiji Kato
- Advantest Corporation, 48-2 Matsubara, Kamiayashi, Aoba-ku, Sendai, Miyagi 989-3124, Japan
| | - Akiyoshi Irisawa
- Advantest Corporation, 48-2 Matsubara, Kamiayashi, Aoba-ku, Sendai, Miyagi 989-3124, Japan
| | - Etsuo Yonemochi
- Faculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan ; PAT Committee, Japan Society of Pharmaceutical Machinery and Engineering, Miyoshi Bld. 3F, 2-7-3 Kandata-cho, Chiyoda-ku, Tokyo 101-0046, Japan
| | - Katsuhide Terada
- Faculty of Pharmaceutical Science, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan ; PAT Committee, Japan Society of Pharmaceutical Machinery and Engineering, Miyoshi Bld. 3F, 2-7-3 Kandata-cho, Chiyoda-ku, Tokyo 101-0046, Japan
| |
Collapse
|
36
|
Rosas JG, Blanco M, González JM, Alcalá M. Quality by design approach of a pharmaceutical gel manufacturing process, part 2: Near infrared monitoring of composition and physical parameters. J Pharm Sci 2011; 100:4442-51. [DOI: 10.1002/jps.22607] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2010] [Revised: 03/08/2011] [Accepted: 04/19/2011] [Indexed: 11/05/2022]
|
37
|
Rosas JG, Blanco M, González JM, Alcalá M. Quality by design approach of a pharmaceutical gel manufacturing process, part 1: Determination of the design space. J Pharm Sci 2011; 100:4432-41. [DOI: 10.1002/jps.22611] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2010] [Revised: 04/08/2011] [Accepted: 04/19/2011] [Indexed: 11/11/2022]
|
38
|
Kushner J. Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development. Pharm Dev Technol 2011; 18:333-42. [DOI: 10.3109/10837450.2011.604784] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
39
|
Process analytical technology applied for end-point detection of pharmaceutical blending by combining two calibration-free methods: Simultaneously monitoring specific near-infrared peak intensity and moving block standard deviation. POWDER TECHNOL 2011. [DOI: 10.1016/j.powtec.2011.03.005] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
40
|
Kushner J, Langdon BA, Hiller JI, Carlson GT. Examining the Impact of Excipient Material Property Variation on Drug Product Quality Attributes: A Quality-By-Design Study for a Roller Compacted, Immediate Release Tablet. J Pharm Sci 2011; 100:2222-39. [DOI: 10.1002/jps.22455] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2010] [Revised: 12/03/2010] [Accepted: 12/03/2010] [Indexed: 11/06/2022]
|
41
|
Wu H, Khan MA. Quality-by-Design: An Integrated Process Analytical Technology Approach to Determine the Nucleation and Growth Mechanisms During a Dynamic Pharmaceutical Coprecipitation Process. J Pharm Sci 2011; 100:1969-86. [DOI: 10.1002/jps.22430] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2010] [Revised: 10/18/2010] [Accepted: 11/08/2010] [Indexed: 11/12/2022]
|
42
|
Adam S, Suzzi D, Radeke C, Khinast JG. An integrated Quality by Design (QbD) approach towards design space definition of a blending unit operation by Discrete Element Method (DEM) simulation. Eur J Pharm Sci 2010; 42:106-15. [PMID: 21056102 DOI: 10.1016/j.ejps.2010.10.013] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2010] [Revised: 09/27/2010] [Accepted: 10/27/2010] [Indexed: 10/18/2022]
Abstract
A combined Quality by Design (QbD) and Discrete Element Model (DEM) simulation-approach is presented to characterize a blending unit operation by evaluating the impact of formulation parameters and process variables on the blending quality and blending end point. Understanding the variability of both the API and the excipients, as well as their impact on the blending process are critical elements for blending QbD. In a first step, the QbD-methodology is systematically used to (1) establish the critical quality attribute content uniformity and to link this CQA to its surrogate blend homogeneity, (2) identify potentially critical input factors that may affect blending operation quality and (3) risk-rank these factors to define activities for process characterization. Subsequently, a DEM-simulation-based characterization of the blending process is performed. A statistical evaluation is finally presented, relating blend homogeneity of systems with low particle number to the regulatory requirements. Data are then used to map out a three-dimensional knowledge space, providing parameters to define a design space and set up an appropriate control strategy.
Collapse
Affiliation(s)
- Siegfried Adam
- Research Center Pharmaceutical Engineering GmbH, Graz, Austria
| | | | | | | |
Collapse
|
43
|
Vogt FG, Kord AS. Development of quality-by-design analytical methods. J Pharm Sci 2010; 100:797-812. [PMID: 21280050 DOI: 10.1002/jps.22325] [Citation(s) in RCA: 136] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2010] [Revised: 07/18/2010] [Accepted: 07/19/2010] [Indexed: 11/11/2022]
Abstract
Quality-by-design (QbD) is a systematic approach to drug development, which begins with predefined objectives, and uses science and risk management approaches to gain product and process understanding and ultimately process control. The concept of QbD can be extended to analytical methods. QbD mandates the definition of a goal for the method, and emphasizes thorough evaluation and scouting of alternative methods in a systematic way to obtain optimal method performance. Candidate methods are then carefully assessed in a structured manner for risks, and are challenged to determine if robustness and ruggedness criteria are satisfied. As a result of these studies, the method performance can be understood and improved if necessary, and a control strategy can be defined to manage risk and ensure the method performs as desired when validated and deployed. In this review, the current state of analytical QbD in the industry is detailed with examples of the application of analytical QbD principles to a range of analytical methods, including high-performance liquid chromatography, Karl Fischer titration for moisture content, vibrational spectroscopy for chemical identification, quantitative color measurement, and trace analysis for genotoxic impurities.
Collapse
Affiliation(s)
- Frederick G Vogt
- Preclinical Development, GlaxoSmithKline plc, 709 Swedeland Road, King of Prussia, Pennsylvania 19406, USA
| | | |
Collapse
|
44
|
Wu H, Khan MA. Quality‐by‐Design (QbD): An Integrated Process Analytical Technology (PAT) Approach for Real‐Time Monitoring and Mapping the State of a Pharmaceutical Coprecipitation Process. J Pharm Sci 2010; 99:1516-34. [DOI: 10.1002/jps.21923] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|